Utilization of Long-Acting Injectable Antipsychotics

The objectives of the query are to describe the following from the years 2017 to 2024: the incidence and prevalence of long-acting injectable (LAI) antipsychotics in Canada and by province; the characteristics of patients who were dispensed LAI antipsychotics in Canada; the incidence and prevalence of LAI antipsychotics by sociodemographic, prescriber type, prior antipsychotic and mental health treatment use, and indicators of mental health and substance use associated with medications; and patient adherence (time on treatment) to LAI antipsychotics in Canada.

Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.